AstraZeneca Reports Its New Vaccine Is Highly Effective

>>Follow Matzav On Whatsapp!<<

More promising vaccine news poured in on Monday, with drugmaker AstraZeneca announcing its COVID-19 vaccine candidate displayed “positive high-level results” following clinical trials. The results are comparable to efficacy rates announced by fellow pharmaceutical companies Moderna and Pfizer.

The company stated in a press release that the vaccine candidate, called AZD1222, was given to thousands of volunteers in interim doses.

When given as a half dose followed by a full dose within a month, the vaccine showed an efficacy rate of 90 percent for a portion of the sample population.

When adding two full doses within a month, the efficacy rate stood at about 62 percent. The combined analysis from these two studies averaged to a 70 percent efficacy rate.

Read more at The Hill.



  1. As Covid-19 was proven to be “The Greatest Hoax Ever Perpetrated On An Unsuspecting Public” why would anyone take the vaccine?
    The truth of the matter is nobody got sick from this political virus and nobody died from this political virus even though fake news proudly boasts every death to be Corona when the fact has well been proven that either people were murdered in hospitals, couldn’t fight the flu shot they were forced to get or died from an existing sickness.

    Top Canadian Pathologist Tells Alberta Government COVID Is “The Greatest Hoax Ever Perpetrated On An Unsuspecting Public”
    “There is utterly unfounded public hysteria driven by the media and politicians, it’s outrageous, this is the greatest hoax ever perpetrated on an unsuspecting public,” said Hodkinson.

  2. How is it that all other vaccines took years to make them “safe and effective” and poof… all the companies all of a sudden made vaccines that are are super effective with excellent safety.

  3. While “highly effective” is much better than “not very effective”, we’d be even happier if it were “super effective”.


Please enter your comment!
Please enter your name here